Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J RIIS

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Calcified Tissue International|September 1, 1986
Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?B J Riis, K Thomsen, C Christiansen
Bone and Mineral|April 1, 1986
Total and local bone mineral during estrogen treatment: a placebo controlled trialA Gotfredsen, B J Riis, C Christiansen
Bone and Mineral|February 1, 1987
Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?B J Riis, L Nilas, C Christiansen
British Journal of Obstetrics and Gynaecology|February 1, 1987
Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteinsJ Jensen, B J Riis, C Christiansen
Calcified Tissue International|December 1, 1990
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal womenD Hartwell, B J Riis, C Christiansen
Pediatric Pulmonology|December 1, 1993
Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonideO D Wolthers, B J Riis, S Pedersen
Ugeskrift for Laeger|January 7, 1998
[Distress symptoms in hospice patients]H Henriksen, J Riis, B Christophersen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 11, 2001
The effect of fluvastatin on parameters of bone remodelingN H Bjarnason, B J Riis, C Christiansen
Acta Psychiatrica Scandinavica|September 1, 1994
Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scaleG Andersen, K Vestergaard, J Riis, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1985
Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in manK Thomsen, B J Riis, L Hummer, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Calcified Tissue International|September 1, 1986
Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?B J Riis, K Thomsen, C Christiansen
Bone and Mineral|April 1, 1986
Total and local bone mineral during estrogen treatment: a placebo controlled trialA Gotfredsen, B J Riis, C Christiansen
Bone and Mineral|February 1, 1987
Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?B J Riis, L Nilas, C Christiansen
British Journal of Obstetrics and Gynaecology|February 1, 1987
Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteinsJ Jensen, B J Riis, C Christiansen
Calcified Tissue International|December 1, 1990
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal womenD Hartwell, B J Riis, C Christiansen
Pediatric Pulmonology|December 1, 1993
Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonideO D Wolthers, B J Riis, S Pedersen
Ugeskrift for Laeger|January 7, 1998
[Distress symptoms in hospice patients]H Henriksen, J Riis, B Christophersen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 11, 2001
The effect of fluvastatin on parameters of bone remodelingN H Bjarnason, B J Riis, C Christiansen
Acta Psychiatrica Scandinavica|September 1, 1994
Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scaleG Andersen, K Vestergaard, J Riis, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1985
Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in manK Thomsen, B J Riis, L Hummer, et al.
Pageof 13